Continued improvement in operating income Extraordinary income from non-recurring instrumentation sales generating investment capacity, to be reinvested in key strategic markets Cash position: €3.2 million, sufficient for upcoming investments Croissy-Beaubourg, September 24, 2019, 5:45pm CEST – THERADIAG (ISIN:…
Croissy-Beaubourg, July 18, 2019, 5.45 pm CET – THERADIAG (ISIN: FR0004197747, Ticker: ALTER), a company specializing in in vitro diagnostics and theranostics, today announced its consolidated first-half revenues for the period ending June 30, 2019.in…
Croissy-Beaubourg, May 14, 2019, 6:00pm CEST – THERADIAG (ISIN: FR0004197747, Ticker: ALTER), a company specialized in in vitro diagnostics and theranostics, is today announcing plans to accelerate its development in the United States, the world’s largest…